Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details) - USD ($) |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Subsidiary, Sale of Stock [Line Items] | |||
Amounts reclassified from unbilled revenue to accounts receivable | $ 19,535,000 | $ 18,306,000 | |
Amounts reclassified from deferred revenue to revenue | 4,989,000 | 4,962,000 | |
Impairment of goodwill | 0 | 6,380,000 | $ 0 |
Impairment of assets | 0 | ||
Subsidiaries | Argentina | |||
Subsidiary, Sale of Stock [Line Items] | |||
Net assets | (12,200,000) | $ (9,800,000) | |
Subsidiaries | Turkey | |||
Subsidiary, Sale of Stock [Line Items] | |||
Net assets | $ 12,100,000 | ||
Subsidiaries | Revenue from Contract with Customer Benchmark | Argentina | Geographic Concentration Risk | |||
Subsidiary, Sale of Stock [Line Items] | |||
Percentage of worldwide total | 3.40% | 3.20% | |
Subsidiaries | Revenue from Contract with Customer Benchmark | Turkey | Geographic Concentration Risk | |||
Subsidiary, Sale of Stock [Line Items] | |||
Percentage of worldwide total | 2.70% |
X | ||||||||||
- Definition Contract With Customer, Asset, New Contract Deductions No definition available.
|
X | ||||||||||
- Definition Contract With Customer, Liability, New Contract Deductions No definition available.
|
X | ||||||||||
- Definition Amount of net assets (liabilities). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|